Breaking News Instant updates and real-time market news.

NVDA

Nvidia

$210.59

8.02 (3.96%)

, ADBE

Adobe

$277.52

-0.03 (-0.01%)

17:37
11/04/19
11/04
17:37
11/04/19
17:37

Adobe apps get 'supercharged' by Nvidia RTX GPUs

Nvidia (NVDA) said in a blog post earlier: "Adobe (ADBE) Dimension, Substance Alchemist and Premiere Pro get a big boost from RTX features, plus new Studio Driver and two new monster RTX Studio Workstations from BOXX. This year, we're helping supercharge creativity with NVIDIA RTX technology. Over 40 top creative and design applications are being accelerated by NVIDIA's RTX ray tracing and AI processors. Meaning, no more waiting on your PC. You're free to create at the speed of your imagination and see your work come to life instantly. Today, this boost is coming to three of Adobe's creative apps: Adobe Dimension, Substance Alchemist and Premiere Pro. From David LaChapelle to M. Night Shyamalan to Dave Grohl, the world's leading creative minds have descended upon Los Angeles this week for Adobe MAX to talk about how technology is improving the way they work.This year, we're helping supercharge creativity with NVIDIA RTX technology. Over 40 top creative and design applications are being accelerated by NVIDIA's RTX ray tracing and AI processors. Meaning, no more waiting on your PC. You're free to create at the speed of your imagination and see your work come to life instantly.Today, this boost is coming to three of Adobe's creative apps: Adobe Dimension, Substance Alchemist and Premiere Pro. Giving 2D Graphics a Third Dimension. 3D design has historically been restricted to programmers and engineers trained in expensive and complicated CAD and DCC tools. At Adobe MAX, the barriers to 3D are crashing down with new apps and capabilities coming to artists' creative portfolios. Adobe Dimension makes it easy and affordable for tens of millions of graphic designers and illustrators to step into 3D with stock assets, point-and-click materials and a powerful new NVIDIA RTX-accelerated ray-traced renderer. Adobe Dimension taps into dedicated ray-tracing processors on RTX GPUs to dramatically speed up rendering of 3D environments. This allows you to see dynamic lighting, beautiful reflections and soft shadows - all without the wait." Reference Link

NVDA

Nvidia

$210.59

8.02 (3.96%)

ADBE

Adobe

$277.52

-0.03 (-0.01%)

  • 04

    Nov

  • 05

    Nov

  • 14

    Nov

  • 20

    Nov

  • 23

    Jan

NVDA Nvidia
$210.59

8.02 (3.96%)

10/21/19
MSCO
10/21/19
NO CHANGE
Target $32
MSCO
Equal Weight
AMD likely to gain share in every segment next year, says Morgan Stanley
Morgan Stanley analyst Joseph Moore said he believes AMD (AMD) has "put itself in a remarkable position" of being poised to likely gain share in every segment next year by competing successfully with both Intel (INTC) and Nvidia (NVDA) while spending a fraction of the R&D those two spend. However, he keeps an Equal Weight rating on AMD shares, stating that his 2020 EPS estimate of $1.07 gives the company "quite a bit of credit for share gains" and the $1.50 in 2020 EPS that some investors are convinced about "is possible, but certainly not a given." Moore, who sees AMD's biggest gains in the "enthusiast desktop," servers for the largest scale cloud service providers, and data center graphics, raised his price target on the stock to $32 from $30.
10/22/19
WELS
10/22/19
NO CHANGE
Target $220
WELS
Outperform
Nvidia price target raised to $220 from $200 at Wells Fargo
Wells Fargo analyst Aaron Rakers raised his price target for Nvidia to $220 from $220, citing its co-founder and CEO Jensen Huang positive keynote presentation at MWC Los Angeles, platform strategy that is continuing to resonate, and an expectation of a return to growth in the company's data center segment. The analyst reiterates an Outperform rating on the shares.
10/25/19
RBCM
10/25/19
NO CHANGE
Target $251
RBCM
Outperform
Nvidia price target raised to $251 from $217 at RBC Capital
RBC Capital analyst Mitch Steves raised his price target on Nvidia (NVDA) to $251 and kept his Outperform rating after the results from Intel (INTC) indicated that data center demand was higher than expected. The analyst contends that Nvidia is also likely to experience a higher growth rate relative to CPU server demand, adding that he is also comfortable with his projections for its gaming business.
11/04/19
CHLM
11/04/19
NO CHANGE
Target $200
CHLM
Hold
Nvidia price target raised to $200 from $165 at Craig-Hallum
Craig-Hallum analyst Richard Shannon raised his price target for Nvidia to $200 from $165 ahead of the company's Q3 results, which he expects to be "strong." In a research note to investors, Shannon says he believes Nvidia's Gaming unit is likely to report upside to consensus estimates based on stronger low-end/mid-range GPU sales and lower channel inventory. Though he views Nvidia's near-term prospects more favorably, Shannon says he is continuing to sit on the sidelines with his Hold rating as he feels valuations remain "stretched" and offer limited upside.
ADBE Adobe
$277.52

-0.03 (-0.01%)

10/16/19
10/16/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Adobe (ADBE) downgraded to Neutral from Buy at Citi with analyst Walter Pritchard saying he believes the stock's risk/reward is "more balanced" with the company's fiscal 2020 guidance "likely to be less conservative." 2. Acuity Brands (AYI) downgraded to Neutral from Outperform at Baird and to Perform from Outperform at Oppenheimer. 3. Costco (COST) downgraded to Neutral from Buy at Northcoast with analyst Chuck Cerankosky citing valuation. 4. ServiceNow (NOW) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Keith Weiss saying the company remains "best-in-class," but it faces increasing near-term risks, including a CFO transition that may result in more cautious initial guidance for FY20 than most investors expect; tougher subscription billings comparisons in the second half of the year; and high expectations with the stock up more than 50% year-to-date. 5. Extraction Oil & Gas (XOG) downgraded to Equal Weight from Overweight at Stephens with analyst Gail Nicholson citing the Q3 production miss, and increased cautiousness around oil. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/17/19
DADA
10/17/19
NO CHANGE
Target $79
DADA
Buy
DocuSign price target raised to $79 from $63 at DA Davidson
DA Davidson analyst Rishi Jaluria raised his price target on DocuSign (DOCU) to $79 and kept his Buy rating after hosting a meeting with its management. The analyst notes the discussions indicated that the company's early Contract Lifecycle Management sales traction is "solid" and should become a larger part of its business. Jaluria adds that while Adobe (ADBE) remains the company's primary competitor, its competitive pressure is "smaller" and growing slower. The analyst further states that DocuSign's international opportunity outside of the English-speaking G20 remains early but is still compelling.
10/27/19
JEFF
10/27/19
NO CHANGE
JEFF
Jefferies expects conservative guidance from Adobe at analyst day
Jefferies analyst Brent Thill maintained a Buy rating and $340 price target on Adobe, which he said remained a top pick. The analyst said he expects Adobe's initial FY20 guidance, given at the company's analyst day on November 4, to "start-off conservatively, especially for the Digital Experience segment." Thill said he would view 18% revenue growth as in-line, and 19%-20% as positive, and noted that Adobe has a "good track record of beating" its guidance.
10/30/19
MSCO
10/30/19
NO CHANGE
Target $340
MSCO
Overweight
Adobe's upcoming analyst day should be catalyst for shares, says Morgan Stanley
Morgan Stanley analyst Keith Weiss previewed Adobe's annual analyst day that the company will host in conjunction with the Adobe Max user conference on November 4, where he expects the company to provide preliminary FY20 targets for revenue, Digital Media Annualized Recurring Revenue, operating margins and EPS. His base case is for net new ARR additions target at $1.4B-$1.5B, which Weiss notes would be a decrease from current FY19 guidance of $1.6B. In this base case, to which he attributes 50% odds, he sees a positive stock reaction of 4%-6%. In a bull case, where Adobe guides to net new ARR of $1.6B and an operating margin outlook of above 42%, Weiss sees the stock up 10% or more and he sess 30% odds of such a scenario. In the bear case, which he assigns 20% odds, Weiss would see the company giving a net new ARR target below $1.4B and pointing to an operating margin below 41%, which he thinks would lead to a 5%-7% pullback in the shares. Ahead of the event, Weiss has an Overweight rating and $340 price target on Adobe shares.

TODAY'S FREE FLY STORIES

21:55
12/09/19
12/09
21:55
12/09/19
21:55
General news
Treasury Market Summary »

Treasury Market Summary:…

AUPH

Aurinia Pharmaceuticals

$15.76

0.31 (2.01%)

21:03
12/09/19
12/09
21:03
12/09/19
21:03
Syndicate
Aurinia Pharmaceuticals 11.1M share Secondary priced at $15.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

GDI

Gardner Denver

$33.90

-0.19 (-0.56%)

20:08
12/09/19
12/09
20:08
12/09/19
20:08
Downgrade
Gardner Denver rating change at BTIG »

Gardner Denver downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GDI

Gardner Denver

$33.90

-0.19 (-0.56%)

19:56
12/09/19
12/09
19:56
12/09/19
19:56
Downgrade
Gardner Denver rating change at BTIG »

Gardner Denver downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DTCWY

Deutsche Wohnen

$0.00

(0.00%)

19:50
12/09/19
12/09
19:50
12/09/19
19:50
Downgrade
Deutsche Wohnen rating change at Goldman Sachs »

Deutsche Wohnen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SEGXF

Segro

$0.00

(0.00%)

19:49
12/09/19
12/09
19:49
12/09/19
19:49
Downgrade
Segro rating change at Goldman Sachs »

Segro downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BORR

Borr Drilling

$6.60

0.46 (7.49%)

19:30
12/09/19
12/09
19:30
12/09/19
19:30
Initiation
Borr Drilling initiated at Goldman Sachs »

Borr Drilling initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INSG

Inseego

$6.89

-0.05 (-0.72%)

19:26
12/09/19
12/09
19:26
12/09/19
19:26
Syndicate
Breaking Syndicate news story on Inseego »

Inseego files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTSV

Forty Seven

$30.44

16.04 (111.39%)

19:25
12/09/19
12/09
19:25
12/09/19
19:25
Conference/Events
Forty Seven to hold an investor event »

Investor Event will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

ARQL

ArQule

$19.71

10.035 (103.77%)

19:25
12/09/19
12/09
19:25
12/09/19
19:25
Conference/Events
ArQule »

Management holds an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

XNCR

Xencor

$41.41

0.39 (0.95%)

19:25
12/09/19
12/09
19:25
12/09/19
19:25
Conference/Events
Xencor to host analyst & investor meeting »

Analyst & Investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

ABR

Arbor Realty

$14.78

(0.00%)

19:20
12/09/19
12/09
19:20
12/09/19
19:20
Syndicate
Arbor Realty 6.5M share Spot Secondary priced at $14.14 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

STRM

Streamline Health

$1.25

-0.04 (-3.10%)

18:59
12/09/19
12/09
18:59
12/09/19
18:59
Hot Stocks
Streamline Health delaying Q3 results to resolve amortization charge »

Streamline Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NLOK

NortonLifeLock

$25.43

-0.02 (-0.08%)

, INTC

Intel

$56.52

-0.28 (-0.49%)

18:55
12/09/19
12/09
18:55
12/09/19
18:55
Periodicals
McAfee weighs combination with NortonLifeLock, WSJ reports »

NortonLifeLock (NLOK) has…

NLOK

NortonLifeLock

$25.43

-0.02 (-0.08%)

INTC

Intel

$56.52

-0.28 (-0.49%)

AVGO

Broadcom

$314.49

-1.68 (-0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 12

    Dec

  • 19

    Dec

  • 23

    Jan

TGTX

TG Therapeutics

$9.28

2.17 (30.52%)

18:55
12/09/19
12/09
18:55
12/09/19
18:55
Conference/Events
TG Therapeutics to host investor & analyst meeting »

Investor & Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

NTNX

Nutanix

$33.87

-0.725 (-2.10%)

18:41
12/09/19
12/09
18:41
12/09/19
18:41
Hot Stocks
Nutanix CEO: We are transitioning to a subscription-based model »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 13

    Dec

  • 16

    Dec

SFIX

Stitch Fix

$25.17

1.04 (4.31%)

, MDB

MongoDB

$131.03

-0.19 (-0.14%)

18:33
12/09/19
12/09
18:33
12/09/19
18:33
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: Stitch…

SFIX

Stitch Fix

$25.17

1.04 (4.31%)

MDB

MongoDB

$131.03

-0.19 (-0.14%)

PHR

Phreesia

$29.01

-0.09 (-0.31%)

CDMO

Avid Bioservices

$5.85

0.05 (0.86%)

MTN

Vail Resorts

$231.30

-1.43 (-0.61%)

TOL

Toll Brothers

$41.40

0.515 (1.26%)

EQ

Equillium

$4.00

-0.03 (-0.74%)

SUPN

Supernus

$22.69

-0.145 (-0.63%)

A

Agilent

$81.68

-0.545 (-0.66%)

HEPA

Hepion Pharmaceuticals

$5.61

0.4 (7.68%)

ROAD

Construction Partners

$20.56

0.66 (3.32%)

CASY

Casey's General Stores

$175.33

-0.47 (-0.27%)

CHWY

Chewy

$24.17

-0.76 (-3.05%)

LVGO

Livongo Health

$27.40

-0.6 (-2.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 10

    Dec

  • 10

    Dec

  • 10

    Dec

  • 10

    Dec

  • 11

    Dec

  • 12

    Dec

  • 18

    Dec

  • 19

    Dec

BLUE

Bluebird Bio

$76.72

-2.79 (-3.51%)

, BMY

Bristol-Myers

$61.32

1.38 (2.30%)

18:24
12/09/19
12/09
18:24
12/09/19
18:24
Hot Stocks
Bluebird Bio, Bristol-Myers present update on Phase 1 study of bb21217 »

Bluebird bio (BLUE) and…

BLUE

Bluebird Bio

$76.72

-2.79 (-3.51%)

BMY

Bristol-Myers

$61.32

1.38 (2.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 11

    Dec

BA

Boeing

$351.25

-2.74 (-0.77%)

18:22
12/09/19
12/09
18:22
12/09/19
18:22
Periodicals
Former Boeing employee Pierson to testify at U.S. House hearing, Reuters says »

An ex-Boeing employee who…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

OXY

Occidental Petroleum

$37.34

-0.07 (-0.19%)

18:21
12/09/19
12/09
18:21
12/09/19
18:21
Hot Stocks
Occidental Petroleum director buys 12.9K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

OXY

Occidental Petroleum

$37.34

-0.07 (-0.19%)

18:14
12/09/19
12/09
18:14
12/09/19
18:14
Hot Stocks
Occidental Petroleum director buys 10K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

EDIT

Editas Medicine

$30.34

-0.6 (-1.94%)

18:02
12/09/19
12/09
18:02
12/09/19
18:02
Hot Stocks
Editas Medicine announces in vivo proof-of-concept data for EDIT-301 »

Editas Medicine announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSB

Mesabi Trust

$23.93

0.71 (3.06%)

, CLF

Cleveland-Cliffs

$8.52

0.38 (4.67%)

17:56
12/09/19
12/09
17:56
12/09/19
17:56
Hot Stocks
Mesabi Trust initiates arbitration against Northshore Mining, Cleveland-Cliffs »

The Trustees of Mesabi…

MSB

Mesabi Trust

$23.93

0.71 (3.06%)

CLF

Cleveland-Cliffs

$8.52

0.38 (4.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FFBC

First Financial Bancorp

$24.67

0.12 (0.49%)

17:51
12/09/19
12/09
17:51
12/09/19
17:51
Hot Stocks
First Financial Bancorp chairman Davis sells 25,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPRE

Green Plains

$14.26

-0.49 (-3.32%)

17:47
12/09/19
12/09
17:47
12/09/19
17:47
Hot Stocks
Green Plains CEO Todd Becker sold over 607K in company shares »

Green Plains CEO Todd…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.